Cedar Brook Financial Partners, LLC Gsk PLC Transaction History

Cedar Brook Financial Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $221,352 - $259,490	-6,497 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$37.87 - $43.58 $1,704 - $1,961	45 Added 0.7%	6,497 $265,000
Q1 2020 May 07, 2020	SELL	$32.47 - $48.83 $357 - $537	-11 Reduced 0.17%	6,452 $244,000
Q4 2019 Feb 06, 2020	BUY	$42.0 - $48.25 $1,260 - $1,447	30 Added 0.47%	6,463 $304,000
Q3 2019 Oct 24, 2019	SELL	$40.46 - $43.52 $3,358 - $3,612	-83 Reduced 1.27%	6,433 $275,000
Q2 2019 Aug 06, 2019	SELL	$39.4 - $42.7 $118 - $128	-3 Reduced 0.05%	6,516 $261,000
Q1 2019 May 08, 2019	SELL	$38.57 - $42.69 $1,697 - $1,878	-44 Reduced 0.67%	6,519 $272,000
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $248,081 - $280,174	6,563 New	6,563 $255,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.